PODD — Insulet Corp. stock price, charts and financials

QT35Insulet Corp.

Insulet Corp. (NASDAQ: PODD) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
143.38
+2.21+1.57%
OverviewShort InterestFilings
PODDQT35Insulet Corp.·NASDAQ
143.38+1.57%
News
Up 1.6% — PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down (zacks.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
BIO-0.90%$349.30MASI+0.00%$179.95GKOS+0.76%$181.38GMED+2.00%$84.00BRKR+4.16%$55.63ALGN+0.57%$174.65SNN-0.17%$30.06PEN+0.39%$325.92
Snapshot
IndexS&P 500P/E26.34EPS (ttm)5.36Insider Own0.87%Shs Outstand69.26MPerf Week-14.62%
Market Cap9.78BForward P/E18.16EPS next Y7.77Insider Trans1.44%Shs Float68.96MPerf Month-10.82%
Enterprise Value10.19BPEG0.45EPS next Q-Inst Own-Short Float6.74%Perf Quarter-11.99%
Income375.48MP/S3.20EPS this Y51.50%Inst Trans-Short Ratio3.02Perf Half Y-41.94%
Sales3.05BP/B6.88EPS next Y19.32%ROA11.86%Short Interest4.65MPerf YTD-50.33%
Book/sh-P/C15.65EPS next 5Y20.88%ROE26.69%52W High360.43 -60.22%Perf Year-49.09%
Cash/sh-P/FCF25.44EPS past 3/5Y275.36% 103.38%ROIC16.04%52W Low128.37 11.69%Perf 3Y-47.47%
Dividend Est.-EV/EBITDA16.00Sales past 3/5Y27.55% 24.54%Gross Margin71.08%Volatility5.12% 3.90%Perf 5Y-49.53%
Dividend TTM-EV/Sales3.34EPS Y/Y TTM-25.61%Oper. Margin16.89%ATR (14)8.77Perf 10Y303.23%
Dividend Ex-Date-Quick Ratio1.83Sales Y/Y TTM40.01%Profit Margin12.29%RSI (14)37.63Recom2.44
Dividend Gr. 3/5Y-Current Ratio2.48EPS Q/Q39.22%SMA20-11.91%Beta1.05Target Price185.18
Payout0.00%Debt/Eq0.67Sales Q/Q33.92%SMA50-8.90%Rel Volume0.99Prev Close141.17
Employees5,400LT Debt/Eq0.68EarningsNov 05SMA200-38.07%Avg Volume1.61MPrice143.38
IPO DateMay 15, 2007Option/ShortYes / YesEPS/Sales Surpr.18.46% 4.36%Net Debt/EBITDA0.65Volume1,587,763Change1.57%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedRobert W. Baird$248 → $175
Aug-06-26ReiteratedBernsteinOutperform$200 → $175
Aug-06-26ReiteratedLeerink PartnersOutperform$145
Aug-06-26ReiteratedRBC CapitalOutperform$245 → $160
Aug-06-26ReiteratedRaymond JamesOutperform$216 → $180
Aug-06-26ReiteratedCanaccord GenuityBuy$249 → $179
Aug-06-26DowngradeTruist SecuritiesBuy → Hold$153
Aug-06-26DowngradeWells FargoOverweight → Equal Weight$144
Aug-06-26DowngradeJP MorganOverweight → Neutral
Aug-06-26DowngradeBTIGBuy → Neutral
Latest News
Today
Today10:25AM
PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Downzacks.com
05:38AM
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuitprnewswire.com
04:32AM
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODDprnewswire.com
Aug-09-26
Aug-09-2609:41AM
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODDnewsfilecorp.com
Aug-08-26
Aug-08-2608:39AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODDnewsfilecorp.com
Aug-07-26
Aug-07-2603:44PM
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuitprnewswire.com
01:09PM
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODDglobenewswire.com
10:11AM
PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firmglobenewswire.com
09:45AM
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Lawglobenewswire.com
07:29AM
PODD UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026newsfilecorp.com
Aug-06-26
Aug-06-2612:20PM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODDnewsfilecorp.com
12:00PM
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harmnewsfilecorp.com
10:11AM
PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact Levi & Korsinskybusinesswire.com
10:09AM
PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action - Contact SueWallStprnewswire.com
08:00AM
Insulet Corporation Is Getting Closer To An Upgrade After Its Large Plungeseekingalpha.com
Company

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,0542,7082,072——————
Cost of Goods Sold Incl. D&A883768626——————
Gross Profit2,1711,9401,446——————
Selling, General and Administrative Excl. Other1,3081,165917——————
Research and Development346301220——————
Other Operating Expense
000——————
Operating Income516474309——————
Interest Expense658043——————
Unusual Expense
—————————
Non-Operating Income (Expense)44-5534——————
Net Income Before Taxes495340300——————
Income Taxes12092-118——————
Consolidated Net Income376247418——————
Net Income From Continuing Operations376247418——————
Net Income376247418——————
EPS (Recurring)5.363.515.97——————
EPS (Basic, Before Extraordinaries)5.363.515.97——————
EPS (Diluted)5.353.485.78——————
EBITDA636532424——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio26.8081.6845.17——————
Price To Sales Ratio3.247.358.82——————
Gross Margin71.0971.6469.79——————
Operating Margin16.9017.5014.91——————
Net Margin12.319.1220.17——————
Shares Outstanding697070——————
Market Capitalization9,89319,89718,275——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$385.75$314.40$243.04$171.68$100.33● Close Price0.00M0.46M0.92M1.38M1.85MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
STONESIFER TIMOTHY C.DirectorJun 03 '26Buy143.512,790400,3939,041Jun 04
BORIO LUCIANADirectorJun 03 '26Sale143.2741859,8874,329Jun 04
MINOGUE MICHAEL RDirectorFeb 25 '26Buy246.232,030499,84717,483Feb 26
McEvoy AshleyPresident and CEOFeb 20 '26Buy239.354,3001,029,20513,916Feb 23
Frederick Wayne A.I.DirectorDec 15 '25Sale293.091,851542,5102,158Dec 16
STONESIFER TIMOTHY C.DirectorDec 05 '25Buy311.73962299,8844,591Dec 08
Singh PremSVP, Global OperationsSep 08 '25Sale347.49687238,7263,456Sep 09
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Option Exercise241.10797192,1614,687Sep 09
Cousin LaetitiaSVP, Reg, Quality & ComplianceSep 08 '25Sale348.81797278,0023,890Sep 09
Benjamin EricEVP, CPXOAug 21 '25Sale332.234,2631,416,29616,736Aug 22
Singh PremSVP, Global OperationsAug 07 '25Option Exercise271.281,343364,3255,486Aug 08
Singh PremSVP, Global OperationsAug 07 '25Sale320.001,343429,7604,143Aug 08
Singh PremSVP, Global OperationsJun 13 '25Sale300.052,327698,2164,143Jun 16
Singh PremSVP, Global OperationsJun 13 '25Option Exercise166.621,257209,4416,470Jun 16
Manea DanSVP, Chief HR OfficerJun 13 '25Sale300.051,300390,0659,090Jun 16
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.